日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Developmental mosaicism underlying EGFR-mutant lung cancer presenting with multiple primary tumors.

EGFR突变型肺癌的发生机制是发育嵌合现象,表现为多原发肿瘤

Burr Risa, Leshchiner Ignaty, Costantino Christina L, Blohmer Martin, Sundaresan Tilak, Cha Justin, Seeger Karsen, Guay Sara, Danysh Brian P, Gore Ira, Jacobs Raquel A, Slowik Kara, Utro Filippo, Rhrissorrakrai Kahn, Levovitz Chaya, Barth Jaimie L, Dubash Taronish, Chirn Brian, Parida Laxmi, Sequist Lecia V, Lennerz Jochen K, Mino-Kenudson Mari, Maheswaran Shyamala, Naxerova Kamila, Getz Gad, Haber Daniel A

Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of patient samples

通过对慢性淋巴细胞白血病(CLL)患者样本进行全外显子组测序,鉴定出与维奈托克耐药相关的遗传事件

Khalsa, Jasneet Kaur; Cha, Justin; Utro, Filippo; Naeem, Aishath; Murali, Ishwarya; Kuang, Yanan; Vasquez, Kevin; Li, Liang; Tyekucheva, Svitlana; Fernandes, Stacey M; Veronese, Lauren; Guieze, Romain; Sasi, Binu Kandathilparambil; Wang, Zixu; Machado, John-Hanson; Bai, Harrison; Alasfour, Maryam; Rhrissorrakrai, Kahn; Levovitz, Chaya; Danysh, Brian P; Slowik, Kara; Jacobs, Raquel A; Davids, Matthew S; Paweletz, Cloud P; Leshchiner, Ignaty; Parida, Laxmi; Getz, Gad; Brown, Jennifer R

Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance

Pirtobrutinib靶向治疗对伊布替尼耐药的慢性淋巴细胞白血病(CLL)中的BTK C481S突变,但第二位点的BTK突变会导致耐药。

Naeem, Aishath; Utro, Filippo; Wang, Qing; Cha, Justin; Vihinen, Mauno; Martindale, Stephen; Zhou, Yinglu; Ren, Yue; Tyekucheva, Svitlana; Kim, Annette S; Fernandes, Stacey M; Saksena, Gordon; Rhrissorrakrai, Kahn; Levovitz, Chaya; Danysh, Brian P; Slowik, Kara; Jacobs, Raquel A; Davids, Matthew S; Lederer, James A; Zain, Rula; Smith, C I Edvard; Leshchiner, Ignaty; Parida, Laxmi; Getz, Gad; Brown, Jennifer R